Individualized radiotherapy by combining high-end irradiation and magnetic resonance imaging
暂无分享,去创建一个
[1] B. Fallone,et al. First MR images obtained during megavoltage photon irradiation from a prototype integrated linac-MR system. , 2009, Medical physics.
[2] Olivier Salvado,et al. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy. , 2012, International journal of radiation oncology, biology, physics.
[3] C. Ménard,et al. Introduction: Systems for magnetic resonance image guided radiation therapy. , 2014, Seminars in radiation oncology.
[4] B W Raaymakers,et al. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose increase at tissue–air interfaces in a lateral magnetic field due to returning electrons , 2005, Physics in medicine and biology.
[5] A. Heuck,et al. MR-Tomographie des Prostatakarzinoms , 2003, Der Radiologe.
[6] T. Gauler,et al. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. , 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[7] Vincent Magnotta,et al. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy. , 2014, International journal of radiation oncology, biology, physics.
[8] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[9] M. Roethke,et al. Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results. , 2015, Neuro-oncology.
[10] David A Jaffray,et al. A facility for magnetic resonance-guided radiation therapy. , 2014, Seminars in radiation oncology.
[11] Tiina Seppälä,et al. A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer. , 2013, Medical physics.
[12] H. Verkooijen,et al. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] R. Shridhar,et al. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[14] C. Hurt,et al. Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer , 2014, International journal of radiation oncology, biology, physics.
[15] B W Raaymakers,et al. Fast dose calculation in magnetic fields with GPUMCD , 2011, Physics in medicine and biology.
[16] C. Bartram,et al. Endorectal ultrasound and magnetic resonance imaging in rectal cancer staging. , 2002, Gastroenterology clinics of North America.
[17] J. Jonsson,et al. Treatment planning of intracranial targets on MRI derived substitute CT data. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] A. Vissink,et al. Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of the parotid gland. , 2006, International journal of radiation oncology, biology, physics.
[19] Jan-Jakob Sonke,et al. The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] C Bert,et al. Motion in radiotherapy: particle therapy , 2011, Physics in medicine and biology.
[21] Julia Bauer,et al. Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] M. Knopp,et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. , 1996, AJR. American journal of roentgenology.
[23] Peter van Luijk,et al. Unexpected changes of rat cervical spinal cord tolerance caused by inhomogeneous dose distributions. , 2003, International journal of radiation oncology, biology, physics.
[24] T. Schuster,et al. Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer , 2014, Strahlentherapie und Onkologie.
[25] A. Graser,et al. [MR imaging of prostate cancer]. , 2003, Der Radiologe.
[26] Stuart Crozier,et al. The Australian magnetic resonance imaging-linac program. , 2014, Seminars in radiation oncology.
[27] Jan J W Lagendijk,et al. The magnetic resonance imaging-linac system. , 2014, Seminars in radiation oncology.
[28] Uwe Haberkorn,et al. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] F. Alongi,et al. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment. , 2014, The British journal of radiology.
[30] H. Paganetti,et al. Dosimetric feasibility of real-time MRI-guided proton therapy. , 2014, Medical physics.
[31] Ion Prostate Irradiation (IPI) – a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique , 2014, BMC Cancer.
[32] L. Remonda,et al. Diffusion tensor imaging for target volume definition in glioblastoma multiforme , 2014, Strahlentherapie und Onkologie.
[33] Sasa Mutic,et al. A Device for Realtime 3D Image-Guided IMRT , 2005 .
[34] P. Hall,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.
[35] Hervé Delingette,et al. Image Guided Personalization of Reaction-Diffusion Type Tumor Growth Models Using Modified Anisotropic Eikonal Equations , 2010, IEEE Transactions on Medical Imaging.
[36] P. Schirmacher,et al. Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer , 2013, Strahlentherapie und Onkologie.
[37] Jan J W Lagendijk,et al. MRI/linac integration. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] Charis Kontaxis,et al. Dosimetric feasibility of intensity modulated proton therapy in a transverse magnetic field of 1.5 T , 2015, Physics in medicine and biology.
[39] M. Gilbert,et al. Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. , 2013, Neuro-oncology.
[40] Wolfgang A Weber,et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.
[41] Jan J W Lagendijk,et al. MR guidance in radiotherapy , 2014, Physics in medicine and biology.
[42] B. Fallone,et al. The rotating biplanar linac-magnetic resonance imaging system. , 2014, Seminars in radiation oncology.
[43] Olivier Clatz,et al. Biocomputing: numerical simulation of glioblastoma growth and comparison with conventional irradiation margins. , 2011, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[44] J. Debus,et al. Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer , 2013, Strahlentherapie und Onkologie.
[45] J. Carl,et al. Differences in supratentorial white matter diffusion after radiotherapy – new biomarker of normal brain tissue damage? , 2013, Acta oncologica.
[46] Maria A Schmidt,et al. Radiotherapy planning using MRI , 2015, Physics in medicine and biology.
[47] V. Goh,et al. Pelvic MRI for guiding treatment decisions in rectal cancer. , 2014, Oncology.
[48] B. Bednarz,et al. Consistency evaluation between EGSnrc and Geant4 charged particle transport in an equilibrium magnetic field , 2013, Physics in medicine and biology.
[49] Sasa Mutic,et al. The ViewRay system: magnetic resonance-guided and controlled radiotherapy. , 2014, Seminars in radiation oncology.
[50] J J W Lagendijk,et al. Dose optimization for the MRI-accelerator: IMRT in the presence of a magnetic field , 2007, Physics in medicine and biology.
[51] M Wannenmacher,et al. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. , 2000, International journal of radiation oncology, biology, physics.
[52] B G Fallone,et al. A deterministic solution of the first order linear Boltzmann transport equation in the presence of external magnetic fields. , 2015, Medical physics.
[53] Lawrence B Marks,et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. , 2005, International journal of radiation oncology, biology, physics.
[54] Geerard L Beets,et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] B W Raaymakers,et al. Magnetic-field-induced dose effects in MR-guided radiotherapy systems: dependence on the magnetic field strength , 2008, Physics in medicine and biology.
[56] Jinsoo Uh,et al. MRI-based treatment planning with pseudo CT generated through atlas registration. , 2014, Medical physics.
[57] E W Steyerberg,et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.
[58] R. Langer,et al. 18F-FDG PET–Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial , 2011, The Journal of Nuclear Medicine.
[59] C. Lambert,et al. A Monte Carlo based formalism to identify potential locations at high risk of tumor recurrence with a numerical model for glioblastoma multiforme. , 2012, Medical physics.
[60] C. Brink,et al. Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose , 2014, Acta oncologica.
[61] Marco Durante,et al. Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes. , 2012, Medical physics.
[62] First Measurement of Signal Changes Induced by Ionizing Radiation in Magnetic Resonance Imaging , 2013 .